Myomo, Inc. (MYO)
NYSEAMERICAN: MYO · IEX Real-Time Price · USD
3.430
+0.010 (0.29%)
At close: Apr 26, 2024, 4:00 PM
3.390
-0.040 (-1.17%)
After-hours: Apr 26, 2024, 4:00 PM EDT

Company Description

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally.

The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.

It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device.

Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders.

The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors.

Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

Myomo, Inc.
Myomo logo
Country United States
IPO Date Jun 12, 2017
Industry Medical Devices
Sector Healthcare
Employees 101
CEO Paul R. Gudonis

Contact Details

Address:
137 Portland Street, 4th Floor
Boston, Massachusetts 02114
United States
Phone 617-996-9058
Website myomo.com

Stock Details

Ticker Symbol MYO
Exchange NYSEAMERICAN
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001369290
CUSIP Number 62857J201
ISIN Number US62857J2015
SIC Code 3842

Key Executives

Name Position
Paul R. Gudonis Chairman, President and Chief Executive Officer
David A. Henry Chief Financial Officer
Dr. Harry Kovelman M.D. Chief Medical Officer
Colin Anderson Global Director of Operations
Joseph Chicoskie Director of Marketing
Galina Shtivelman Senior Director of Human Resources
Micah J. Mitchell Chief Commercial Officer

Latest SEC Filings

Date Type Title
Apr 26, 2024 ARS Filing
Apr 26, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 26, 2024 DEF 14A Other definitive proxy statements
Apr 25, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Apr 2, 2024 144 Filing
Mar 28, 2024 8-K Current Report
Mar 11, 2024 144 Filing
Mar 11, 2024 144 Filing
Mar 11, 2024 144 Filing
Mar 8, 2024 10-K Annual Report